Apoptosis of Mdm2-deficient osteocytes enhances osteogenesis through TRPM8-enriched apoptotic vesicles

Abstract

During homeostasis, osteocyte apoptosis is typically associated with bone loss through enhanced osteoclast recruitment and bone resorption. However, whether apoptotic osteocytes also regulate bone formation remains elusive. Here we report that conditional deletion of Mdm2, an E3 ubiquitin ligase regulating cell survival, causes osteocyte apoptosis but paradoxically results in a marked increase in bone mass attributed to up-regulated osteogenic activity. Single-cell RNA sequencing reveals enhanced osteoblastic differentiation of bone marrow mesenchymal stem cells (BMSCs) in conditional knockout mice, with enrichment of cellular calcium related pathways. Mechanistically, apoptotic vesicles (apovs) from Mdm2-deleted osteocytes are engulfed by BMSCs. TRPM8, a calcium channel protein, is enriched in osteocyte-derived apovs and transported into BMSCs, thereby promoting osteoblastic differentiation. Additionally, pharmacological inhibition of TRPM8 attenuates the high bone mass phenotype in conditional knockout mice. Therefore, Mdm2 deletion in osteocytes leads to osteocyte apoptosis, which enhances bone formation through communicating with BMSCs via TRPM8-enriched apovs. Our findings underscore the pivotal role of osteocytes in bone homeostasis and unveil a previously unrecognized mechanism whereby osteocyte apoptosis stimulates osteogenesis through affecting the fate of BMSCs in a TRPM8-mediated paracrine mechanism.

References

[1] Hadjidakis DJ, Androulakis II. Bone remodeling. Ann. N. Y. Acad. Sci., 2006, 1092: 385-396

[2] Kenkre JS, Bassett J. The bone remodelling cycle. Ann. Clin. Biochem, 2018, 55: 308-327

[3] Atkins GJ, Findlay DM. Osteocyte regulation of bone mineral: a little give and take. Osteoporos. Int., 2012, 23: 2067-2079

[4] Bonewald LF. The amazing osteocyte. J. Bone Miner. Res., 2011, 26: 229-238

[5] Schaffler MB, Kennedy OD. Osteocyte signaling in bone. Curr. Osteoporos. Rep., 2012, 10: 118-125

[6] Delgado-Calle J, Bellido T. The osteocyte as a signaling cell. Physiol. Rev., 2022, 102: 379-410

[7] Chen H, Senda T, Kubo KY. The osteocyte plays multiple roles in bone remodeling and mineral homeostasis. Med. Mol. Morphol., 2015, 48: 61-68

[8] Robling AG, Bonewald LF. The osteocyte: new insights. Annu. Rev. Physiol., 2020, 82: 485-506

[9] Dudley HR, Spiro D. The fine structure of bone cells. J. Biophys. Biochem. Cytol., 1961, 11: 627-649

[10] Tatsumi S, et al.. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab., 2007, 5: 464-475

[11] Cabahug-Zuckerman P, et al.. Osteocyte apoptosis caused by hindlimb unloading is required to trigger osteocyte RANKL production and subsequent resorption of cortical and trabecular bone in mice femurs. J. Bone Miner. Res., 2016, 31: 1356-1365

[12] Cao H, et al.. Focal adhesion protein Kindlin-2 regulates bone homeostasis in mice. Bone Res., 2020, 8: 2

[13] McCutcheon S, Majeska RJ, Spray DC, Schaffler MB, Vazquez M. Apoptotic osteocytes induce RANKL production in bystanders via purinergic signaling and activation of pannexin channels. J. Bone Miner. Res., 2020, 35: 966-977

[14] Patergnani S, et al.. The inhibition of MDM2 slows cell proliferation and activates apoptosis in ADPKD cell lines. Biol. Cell, 2023, 115 ArticleID: e2200037

[15] Karni-Schmidt O, Lokshin M, Prives C. The roles of MDM2 and MDMX in cancer. Annu Rev. Pathol., 2016, 11: 617-644

[16] Zheng H, Yang G, Fu J, Chen Z, Yuan G. Mdm2 promotes odontoblast-like differentiation by ubiquitinating Dlx3 and p53. J. Dent. Res., 2020, 99: 320-328

[17] Zheng H, Fu J, Chen Z, Yang G, Yuan G. Dlx3 ubiquitination by nuclear Mdm2 is essential for dentinogenesis in mice. J. Dent. Res., 2022, 101: 1064-1074

[18] Fahraeus R, Olivares-Illana V. MDM2’s social network. Oncogene, 2014, 33: 4365-4376

[19] Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature, 1997, 387: 296-299

[20] Manfe V, et al.. MDM2 inhibitor nutlin-3a induces apoptosis and senescence in cutaneous T-cell lymphoma: role of p53. J. Invest. Dermatol., 2012, 132: 1487-1496

[21] Montes de Oca Luna R, Wagner DS, Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature, 1995, 378: 203-206

[22] Wen W, et al.. Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stability. Oncogene, 2014, 33: 421-428

[23] Zauli G, et al.. MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway. J. Bone Miner. Res., 2007, 22: 1621-1630

[24] Lengner CJ, et al.. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J. Cell Biol., 2006, 172: 909-921

[25] Aubrey BJ, Kelly GL, Janic A, Herold MJ, Strasser A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?. Cell Death Differ., 2018, 25: 104-113

[26] Whyte MP. Osteopetrosis: discovery and early history of “marble bone disease”. Bone, 2023, 171 ArticleID: 116737

[27] Liang B, Burley G, Lin S, Shi YC. Osteoporosis pathogenesis and treatment: existing and emerging avenues. Cell Mol. Biol. Lett., 2022, 27: 72

[28] Feng X, McDonald JM. Disorders of bone remodeling. Annu. Rev. Pathol., 2011, 6: 121-145

[29] Debnath S, et al.. Discovery of a periosteal stem cell mediating intramembranous bone formation. Nature, 2018, 562: 133-139

[30] Omatsu Y, et al.. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity, 2010, 33: 387-399

[31] Seike M, Omatsu Y, Watanabe H, Kondoh G, Nagasawa T. Stem cell niche-specific Ebf3 maintains the bone marrow cavity. Genes Dev., 2018, 32: 359-372

[32] Ji X, et al.. Genetic activation of glycolysis in osteoblasts preserves bone mass in type I diabetes. Cell Chem. Biol., 2023, 30: 1053-1063 e1055

[33] Zhong, L. et al. Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment. Elife9, e54695 (2020).

[34] Sivaraj KK, et al.. Regional specialization and fate specification of bone stromal cells in skeletal development. Cell Rep., 2021, 36 ArticleID: 109352

[35] Kito, H. & Ohya, S. Role of K⁺ and Ca²⁺-permeable channels in osteoblast functions. Int. J. Mol. Sci.22, 10459 (2021).

[36] Guo J, et al.. N-(3-oxododecanoyl)-homoserine lactone regulates osteoblast apoptosis and differentiation by mediating intracellular calcium. Cell Signal., 2020, 75 ArticleID: 109740

[37] Kakarla R, Hur J, Kim YJ, Kim J, Chwae YJ. Apoptotic cell-derived exosomes: messages from dying cells. Exp. Mol. Med., 2020, 52: 1-6

[38] Zhang X, et al.. Proteomic analysis of MSC-derived apoptotic vesicles identifies Fas inheritance to ameliorate haemophilia a via activating platelet functions. J. Extracell. Vesicles, 2022, 11 ArticleID: e12240

[39] Yin Y, et al.. Activation mechanism of the mouse cold-sensing TRPM8 channel by cooling agonist and PIP(2). Science, 2022, 378 ArticleID: eadd1268

[40] Tang Z, et al.. Pirt functions as an endogenous regulator of TRPM8. Nat. Commun., 2013, 4 ArticleID: 2179

[41] Liu B, Qin F. Functional control of cold- and menthol-sensitive TRPM8 ion channels by phosphatidylinositol 4,5-bisphosphate. J. Neurosci., 2005, 25: 1674-1681

[42] Schuler M, Green DR. Transcription, apoptosis and p53: catch-22. Trends Genet., 2005, 21: 182-187

[43] Asuthkar S, Velpula KK, Elustondo PA, Demirkhanyan L, Zakharian E. TRPM8 channel as a novel molecular target in androgen-regulated prostate cancer cells. Oncotarget, 2015, 6: 17221-17236

[44] Ding, P. et al. Osteocytes regulate senescence of bone and bone marrow. Elife11, e81480 (2022).

[45] Farr, J. N. et al. Local senolysis in aged mice only partially replicates the benefits of systemic senolysis. J. Clin. Invest.133, e162519 (2023).

[46] Andreev D, et al.. Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin. J. Clin. Invest., 2020, 130: 4811-4830

[47] McKenzie J, et al.. Osteocyte death and bone overgrowth in mice lacking fibroblast growth factor receptors 1 and 2 in mature osteoblasts and osteocytes. J. Bone Miner. Res., 2019, 34: 1660-1675

[48] Hoover MY, et al.. Purification and functional characterization of novel human skeletal stem cell lineages. Nat. Protoc., 2023, 18: 2256-2282

[49] Shu HS, et al.. Tracing the skeletal progenitor transition during postnatal bone formation. Cell Stem Cell, 2021, 28: 2122-2136 e2123

[50] Deng P, et al.. Loss of KDM4B exacerbates bone-fat imbalance and mesenchymal stromal cell exhaustion in skeletal aging. Cell Stem Cell, 2021, 28: 1057-1073 e1057

[51] Lim J, Burclaff J, He G, Mills JC, Long F. Unintended targeting of Dmp1-Cre reveals a critical role for Bmpr1a signaling in the gastrointestinal mesenchyme of adult mice. Bone Res., 2017, 5 ArticleID: 16049

[52] Nakamura T, et al.. Generation of bicistronic Dmp1-Cre knock-in mice using a self-cleaving 2A peptide. J. Bone Min. Metab., 2023, 41: 470-480

[53] Liu F, et al.. Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues. Int. J. Dev. Biol., 2004, 48: 645-653

[54] Poon IKH, et al.. Moving beyond size and phosphatidylserine exposure: evidence for a diversity of apoptotic cell-derived extracellular vesicles in vitro. J. Extracell. Vesicles, 2019, 8 ArticleID: 1608786

[55] Ma Q, et al.. Mature osteoclast-derived apoptotic bodies promote osteogenic differentiation via RANKL-mediated reverse signaling. J. Biol. Chem., 2019, 294: 11240-11247

[56] Zhu Y, et al.. Apoptotic vesicles regulate bone metabolism via the miR1324/SNX14/SMAD1/5 signaling axis. Small, 2023, 19 ArticleID: e2205813

[57] Liu D, et al.. Circulating apoptotic bodies maintain mesenchymal stem cell homeostasis and ameliorate osteopenia via transferring multiple cellular factors. Cell Res., 2018, 28: 918-933

[58] Jiang Y, et al.. Apoptotic vesicles rectify senile bone-fat imbalance by activating Thy1-ERK-TAZ axis. J. Nanobiotechnology, 2025, 24 ArticleID: 45

[59] O’Brien K, Breyne K, Ughetto S, Laurent LC, Breakefield XO. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat. Rev. Mol. Cell Biol., 2020, 21: 585-606

[60] Akers JC, Gonda D, Kim R, Carter BS, Chen CC. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J. Neuro-oncol., 2013, 113: 1-11

[61] Henao JC, et al.. TRPM8 channel promotes the osteogenic differentiation in human bone marrow mesenchymal stem cells. Front. Cell Dev. Biol., 2021, 9 ArticleID: 592946

[62] Fonfria E, et al.. Tissue distribution profiles of the human TRPM cation channel family. J. Recept Signal Transduct. Res., 2006, 26: 159-178

[63] Gou X, et al.. Gelatinases cleave dentin sialoprotein intracellularly. Front. Physiol., 2020, 11: 686

[64] Stern AR, Bonewald LF. Isolation of osteocytes from mature and aged murine bone. Methods Mol. Biol., 2015, 1226: 3-10

[65] Shah KM, et al.. Osteocyte isolation and culture methods. Bonekey Rep., 2016, 5: 838

[66] Agoro R, et al.. Single cell cortical bone transcriptomics define novel osteolineage gene sets altered in chronic kidney disease. Front. Endocrinol., 2023, 14 ArticleID: 1063083

[67] Soleimani M, Nadri S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat. Protoc., 2009, 4: 102-106

[68] Fu J, et al.. WWP2 promotes odontoblastic differentiation by monoubiquitinating KLF5. J. Dent. Res., 2021, 100: 432-439

Funding

National Natural Science Foundation of China (National Science Foundation of China)(82370913)

Fundamental Research Funds for the Central Universities (2042026kf0003) Fundamental Research Funds for the Central Universities (2042022dx0003)

National Natural Science Foundation of China Key Program (82230029)

National Natural Science Foundation of China (82270947)

RIGHTS & PERMISSIONS

The Author(s)